Image

Global Biochips Market – Industry Trends and Forecast to 2028

Healthcare

Image

Global Biochips Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • May 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Biochips Market – Industry Trends and Forecast to 2028

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2028
Diagram Market Size (Base Year) USD MILLION
Diagram Market Size (Forecast Year) USD 46.88 USD Billion
Diagram CAGR %

Major Markets Players

  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • and others

Global Biochips Market, By Product Type (DNA Chip, Lab-on-a-Chip, Protein Chips, Other Arrays), Fabrication Technology (Microarrays, Microfluidics), Application (Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, Other Applications), End User (Hospital, Diagnostic Centers, Biotechnology & Pharmaceutical Companies, Academic & Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Biochips Market Market Analysis and Insights : Global Biochips Market

The biochips market is expected to witness market growth at a rate of 14.22% in the forecast period of 2021 to 2028 and is expected to reach USD 67,084.67 million by 2028. Data Bridge Market Research report on biochips market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in demand for the product for various applications is escalating the growth of biochips market.

Biochips refer to a miniaturized device that is capable of performing thousands of biochemical reactions and are used in molecular biology. Their unique features include thousands of biochemical reactions and are used in molecular biology. These are utilized in various applications such as research application in biotechnology such as genomics and proteomics, molecular diagnostics and drug screening and development.

The presence of comprehensive drug development pip acts as one of the major factors driving the growth of biochips market. The rise in the need to reduce turnaround time and miniaturize biological and clinical tests used for research and diagnosis increasing demand for biochip and bio-array techniques and rapid technical developments related to these techniques and a wide product portfolio accelerate the biochips market growth. Their use in various applications ranging from disease marker identification to accelerated drug development, including a number of research applications in fields of genotyping, proteomics and genomics and rise in the spending on the clinical research along with substantial resource allocation for genomic and proteomic research further influence the biochips market. Additionally, growth in aging population, improving healthcare infrastructure and surge in healthcare expenditure positively affect the biochips market. Furthermore, new product launches extend profitable opportunities to the biochips market players in the forecast period of 2021 to 2028.

On the other hand, high cost associated with the instrumentation and absolute quantification of specific MRNA expressions is the factors expected to obstruct the biochips market growth. Complexity of biological systems and unclear regulatory guidelines are projected to challenge the biochips market in the forecast period of 2021-2028.

This biochips market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biochips market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Biochips Market Scope and Market Size

The biochips market is segmented on the basis of product type, fabrication technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of product type, the biochips market is segmented into dna chip, lab-on-a-chip, protein chips and other arrays.
  • On the basis of fabrication technology, the biochips market is segmented into microarrays and microfluidics.
  • On the basis of application, the biochips market is segmented into drug discovery and development, disease diagnostics, genomics, proteomics, agriculture and other applications.
  • On the basis of end user, the biochips market is segmented into hospital, diagnostic centers, biotechnology and pharmaceutical companies and academic and research institutes.

Global Biochips Market Country Level Analysis

The biochips market is analyzed and market size insights and trends are provided by country, product type, fabrication technology, application and end user as referenced above.      

The countries covered in the global biochips market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the biochips market due to the increasing aging population and rising prevalence of lifestyle diseases and cardiac disorders within the region. Asia-Pacific is expected to witness the fastest growth during the forecast period of 2021 because of the rapid growth in the life sciences industry in China and India, low infrastructure costs and growth in biotechnology and pharmaceutical research in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The biochips market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biochips market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biochips market. The data is available for historic period 2011 to 2019. 

Competitive Landscape and Biochips Market Share Analysis

The biochips market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to biochips market.

The major players covered in the biochips market report are Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd, Cepheid, Bio-Rad Laboratories, Inc., GENERAL ELECTRIC, Illumina, Inc., Fluidigm, PerkinElmer Inc., Agilent Technologies, Inc., Arbor Biosciences, Now Elim Biopharm, Inc., Genalyte, Inc., Hologic, Inc., Agendia, Illumina, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The biochips market size will be worth USD 67,084.67 million by 2028.
The growth rate of the biochips market is 14.22%.
The presence of comprehensive drug development pip & the rise in the need to reduce turnaround time and miniaturize biological and clinical tests used for research and diagnosis are the growth drivers of the biochips market.
Product type, fabrication technology, application and end user are the factors on which the biochips market research is based.
Major companies in the biochips market are Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd, Cepheid, Bio-Rad Laboratories, Inc., GENERAL ELECTRIC, Illumina, Inc., Fluidigm, PerkinElmer Inc., Agilent Technologies, Inc., Arbor Biosciences, Now Elim Biopharm, Inc., Genalyte, Inc., Hologic, Inc., Agendia, Illumina, Inc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials